MedTrace Logo

A Comparative Study of Glucocorticoids Efficacy in Acute Respiratory Distress Syndrome

NCT06496997 · Status: RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2025-01-06

No results posted yet for this study

Summary

The aim of the work is to compare the efficacy of equivalent doses of methylprednisolone, dexamethasone and hydrocortisone in patients with ARDS

Conditions

  • Acute Respiratory Distress Syndrome

Interventions

DRUG

Dexamethasone

Dexamethasone at an equivalent dose of 13 mg/day

DRUG

Hydrocortisone

Hydrocortisone at an equivalent dose of 350 mg/day

DRUG

Methylprednisolone

Methylprednisolone at a dose of 1 mg/kg/day (an average dose of 70 mg/day based on 70 kg body weight)

Sponsors & Collaborators

  • Fayoum University

    lead OTHER

Principal Investigators

  • Mahmoud Ezzat Elkmash, Teaching Assistant · Faculty of Pharmacy - Fayoum University

  • Raghda Roshdy Hussein, Assistant Professor · Faculty of Pharmacy - Beni Suef University

  • Marwa Kamal Tolba, Assistant Professor · Faculty of Pharmacy - Fayoum University

  • Marian Sobhi Saeed, Lecturer · Faculty of Pharmacy - Beni Suef University

  • Mona Ibrahim Ahmed, Lecturer · Faculty of Medicine - Fayoum University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-08-31
Completion
2025-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06496997 on ClinicalTrials.gov